or Try an Advanced Search...

    Gene Editing Stocks List

    Symbol Grade Name % Change
    PRME F Prime Medicine, Inc. 6.93
    MGX F Metagenomi, Inc. -11.65
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biotechnology Genetic Engineering Molecular Biology Biological Engineering CRISPR Disease Emerging Technologies Gene Editing Technology Genome Editing Human Cancer Life Sciences Medical Genetics

    Related ETFs - A few ETFs which own one or more of the above listed Gene Editing stocks.

    Symbol Grade Name Weight
    LRNZ C TrueMark Technology, AI & Deep Learning ETF 1.06
    ARKG D ARK Genomic Revolution Multi-Sector ETF 1.01
    ARKK D ARK Innovation ETF 0.18
    BTEC C Principal Healthcare Innovators Index ETF 0.13
    IBBQ C Invesco Nasdaq Biotechnology ETF 0.06
    View all Gene Editing ETFs...
    Compare ETFs
    Compare ARKG to BTEC Compare ARKK to BTEC Compare LRNZ to BTEC

        Gene Editing Stocks Recent News

        Date Stock Title
        May 2 PRME Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
        May 1 MGX Metagenomi, Moderna terminate gene editing collaboration
        May 1 MGX Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
        May 1 PRME Prime Medicine to Participate in the 27th Annual Milken Institute Global Conference
        Apr 30 PRME Prime Medicine gets green light for trials of first-ever prime editing drug
        Apr 29 PRME FDA clears Prime Medicine to begin gene therapy clinical testing
        Apr 29 PRME Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
        Apr 29 PRME Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
        Apr 29 PRME Prime gets FDA green light to begin first trial test of ‘prime editing’
        Apr 29 PRME Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
        Related Industries: Biotechnology
        Related Stock Lists: Biotechnology Genetic Engineering Molecular Biology Biological Engineering CRISPR Disease Emerging Technologies Gene Editing Technology Genome Editing Human Cancer Life Sciences Medical Genetics
        Gene Editing

        Browse All Tags